1-1 of 1
Keywords: Low-dose bacillus Calmette-Guérin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus Calmette-Guérin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and Treat Carcinoma in situ: A Multi-Institutional Retrospective Study

Open Access
Subject Area:
Topic Article Package: ADC (Antibody-Drug Conjugates) , Karger e-Journal Backfile Collection 2023 , Further Areas
Takashi Tachibana, Masaomi Ikeda, Soichiro Shimura, Noriyuki Amano, Yasukiyo Murakami, Yasufumi Yamada, Dai Koguchi, Ryota Maeyama, Mizuho Kawamura, Yusuke Sakata, Masahiro Hagiwara, Kazumasa Matsumoto, Masatsugu Iwamura
Journal: Urologia Internationalis
Urol Int (2023) 107 (3): 230–238.
https://doi.org/10.1159/000527718
Published Online: 22 March 2023
... to in the content or advertisements. 2023 Low-dose bacillus Calmette-Guérin Tokyo-172 strain Induction therapy Non-muscle-invasive bladder cancer Carcinoma in situ Worldwide, bladder cancer (BC) is the tenth most commonly diagnosed cancer. The worldwide age-standardized incidence rate (per...
View article titled, Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus Calmette-Guérin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and Treat Carcinoma in situ: A Multi-Institutional Retrospective Study
Open the PDF for Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus Calmette-Guérin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and Treat Carcinoma in situ: A Multi-Institutional Retrospective Study in another window